Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shougeng Liu"'
Autor:
Jianmin Wang, Cheng Yang, Huashen Xu, Xinyu Fan, Lina Jia, Yang Du, Shougeng Liu, Wenjing Wang, Jie Zhang, Yu Zhang, Xiaoxue Wang, Zhongbo Liu, Jie Bao, Songping Li, Jingyu Yang, Chunfu Wu, Jing Tang, Guoliang Chen, Lihui Wang
Publikováno v:
Advanced Science, Vol 11, Iss 7, Pp n/a-n/a (2024)
Abstract Interactions between oncogenic proteins contribute to the phenotype and drug resistance. Here, EZH2 (enhancer of zest homolog 2) is identified as a crucial factor that mediates HIF‐1 (hypoxia‐inducible factor) inhibitor resistance. Mecha
Externí odkaz:
https://doaj.org/article/fa2b2c700c7e4c0fa2cf0b1ae9bc1ab8
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
As a reversible and dynamic epigenetic modification, N6-methyladenosine (m6A) modification is ubiquitous in eukaryotic cells. m6A methylation is prevalent in almost all RNA metabolism processes that affect the fate of cells, including cancer developm
Externí odkaz:
https://doaj.org/article/2a6f5961137a41a192a3858a20ca7fdd
Autor:
Sihong, Chen, Yingxi, Zhao, Shougeng, Liu, Jiayu, Zhang, Yehuda G, Assaraf, Wei, Cui, Lihui, Wang
Publikováno v:
Drug Resistance Updates. 61:100821
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the frequent emergence of drug resistance leads to disease progression or tumor recurrence resulting in dismal prognosis. Given that genetic mutations are thought to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b1fa99e742eced46fdf2cdb4efe013
https://doi.org/10.1016/j.drup.2022.100821
https://doi.org/10.1016/j.drup.2022.100821